» Articles » PMID: 25605490

Association Between P53 Codon 72 (Arg72Pro) Polymorphism and Primary Open-angle Glaucoma in Iranian Patients

Overview
Journal Iran Biomed J
Date 2015 Jan 22
PMID 25605490
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Glaucomatous neuropathy is a type of cell death due to apoptosis. The p53 gene is one of the regulatory genes of apoptosis. Recently, the association between the p53 gene encoding for proline at codon 72 and primary open-angle glaucoma (POAG) has been studied in some ethnic groups. This study is the first association analysis of POAG and p53 codon 72 polymorphism in Iranian patients.

Methods: A cohort of 65 unrelated patients with POAG (age range from 12-62 years, mean ± SD of 40.16 ± 17.51 years) and 65 unrelated control subjects (without glaucoma, age range of 14-63 years, mean ± SD of 35.64 ± 13.61 years) were selected. In Iranian POAG patients and normal healthy controls, the p53 codon 72 polymorphism in exon 4 was amplified using polymerase chain reaction. The amplified DNA fragments were digested with the BstUI restriction enzyme, and the digestion patterns were used to identify the alleles for the polymorphic site.

Results: Comparisons revealed significant differences in allele and genotype frequencies of Pro72Arg between POAG patients and control group. A higher risk of POAG was associated with allele Pro (OR = 2.1, 95% CI = 1.2-3.4) and genotype Pro/Pro (OR = 3.9, 95% CI = 0.13-12.7).

Conclusion: The p53 Pro72 allele was more frequent in Iranian POAG patients than in the control group (P<0.05). The present findings show that the individuals with the Pro/Pro genotype may be more likely to develop POAG. However, additional studies are necessary to confirm this association.

Citing Articles

Apoptosis in glaucoma: A new direction for the treatment of glaucoma (Review).

Xia Q, Zhang D Mol Med Rep. 2024; 29(5).

PMID: 38516770 PMC: 10975112. DOI: 10.3892/mmr.2024.13207.


The Role of Mitophagy in Glaucomatous Neurodegeneration.

Stavropoulos D, Grewal M, Petriti B, Chau K, Hammond C, Garway-Heath D Cells. 2023; 12(15).

PMID: 37566048 PMC: 10417839. DOI: 10.3390/cells12151969.


Prevalence Rates and Risk Factors for Primary Open Angle Glaucoma in the Middle East.

Torabi R, Harris A, Siesky B, Zukerman R, Oddone F, Mathew S J Ophthalmic Vis Res. 2021; 16(4):644-656.

PMID: 34840687 PMC: 8593541. DOI: 10.18502/jovr.v16i4.9755.


Association of Mouse Double Minute 2 -309T>G Polymorphism with Acute Myeloid Leukemia in an Iranian Population: A Case- Control Study.

Soleymannejad M, Sheikhha M, Neamatzadeh H Asian Pac J Cancer Prev. 2019; 20(10):3037-3041.

PMID: 31653152 PMC: 6982679. DOI: 10.31557/APJCP.2019.20.10.3037.


Association of MTHFR C677T and A1298C Polymorphisms with Glaucoma Risk: a Systematic Review Meta-Analysis based 42 Case-Control Studies.

Gohari M, Mirjalili S, Akbarian-Bafghi M, Jarahzadeh M, Zare-Shehneh M, Neamatzadeh H Rom J Ophthalmol. 2019; 63(2):107-118.

PMID: 31334388 PMC: 6626931.


References
1.
Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F . Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature. 1998; 393(6682):229-34. DOI: 10.1038/30400. View

2.
Shi H, Tan S, Zhong H, Hu W, Levine A, Xiao C . Winter temperature and UV are tightly linked to genetic changes in the p53 tumor suppressor pathway in Eastern Asia. Am J Hum Genet. 2009; 84(4):534-41. PMC: 2667983. DOI: 10.1016/j.ajhg.2009.03.009. View

3.
Moore D, Harris A, WuDunn D, Kheradiya N, Siesky B . Dysfunctional regulation of ocular blood flow: A risk factor for glaucoma?. Clin Ophthalmol. 2009; 2(4):849-61. PMC: 2699797. DOI: 10.2147/opth.s2774. View

4.
Blanco-Marchite C, Sanchez-Sanchez F, Lopez-Garrido M, Inigez-de-Onzono M, Lopez-Martinez F, Lopez-Sanchez E . WDR36 and P53 gene variants and susceptibility to primary open-angle glaucoma: analysis of gene-gene interactions. Invest Ophthalmol Vis Sci. 2011; 52(11):8467-78. PMC: 3208188. DOI: 10.1167/iovs.11-7489. View

5.
Fan B, Wiggs J . Glaucoma: genes, phenotypes, and new directions for therapy. J Clin Invest. 2010; 120(9):3064-72. PMC: 2929733. DOI: 10.1172/JCI43085. View